Advertisement
News
Subscribe to MDT Magazine News

Via Oncology Pathways Now Incorporate Advance Care Planning Decision Support

May 4, 2011 8:40 am | by Bio-Medicine.Org | Comments

PITTSBURGH, May 4, 2011 /- The most recent release of Via Oncology Pathways from D3 Oncology Solutions (D3) now includes decision support for advance care planning to encourage early discussions between oncologists and their patients about the disease, treatment intent and likely...

TOPICS:

Boston Scientific reports stolen medical devices

May 4, 2011 7:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Boston Scientific Corp. has announced that a shipment of medical devices was stolen last month on its way to the company's sterilization facility. The Natick-based medical device company said that the devices, which include endoscopy and urology/women's health devices, could cause...

TOPICS:

Kimberly-Clark Health Care Presents an OR-Liveâ„¢ Premiere Webcast - Endoscopic Placement Method of Balloon-Retained Feeding Tubes

May 4, 2011 6:43 am | by Bio-Medicine.Org | Comments

ROSWELL, Ga., May 4, 2011 /- Kimberly-Clark Health Care today posted a sneak peek preview of an upcoming OR-Live™ webcast of its innovative method for percutaneous endoscopic placement of balloon-retained enteral feeding tubes on its website www.kcdigestivehealth.com . The procedure...

TOPICS:
Advertisement

Simulated Environment Concepts to be Featured in Interview Series

May 4, 2011 6:43 am | by Bio-Medicine.Org | Comments

MIAMI, May 4, 2011 /- Simulated Environment Concepts ( SMEV ), manufacturer and developer of medical, aesthetic, weight loss, wellness, and slimming equipment, announced that Dr. Ella Frenkel, President and CEO of Simulated Environment Concepts (SE Concepts) and the company's COO, Mr....

TOPICS:

Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10

May 4, 2011 5:38 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 4, 2011 /- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today announced it will report first quarter 2011 financial results after the NASDAQ Global Select Market closes on Tuesday, May 10, 2011. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer,...

TOPICS:

China Sky One Medical Announces Conference Call to Discuss First Quarter 2011 Results

May 4, 2011 5:35 am | by Bio-Medicine.Org | Comments

HARBIN, China, May 4, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (NASDAQ: CSKI ), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that it will conduct a conference...

TOPICS:

Volcano Corporation Presentation at Bank of America Merrill Lynch Conference to be Webcast

May 4, 2011 5:35 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 4, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in...

TOPICS:

Boston Scientific Devices Stolen – Risk of Infection

May 4, 2011 4:30 am | by U.S. Food & Drug Administration | Comments

Labels on these devices state that they are “Sterile”; however, they were stolen prior to being sterilized and are non-sterile.

TOPICS:
Advertisement

Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Pancreatic Cancer

May 4, 2011 3:37 am | by Bio-Medicine.Org | Comments

NEW YORK, May 4, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Leukemia, Lymphoma and Pancreatic Cancer http://www.reportlinker.com/p0284821/Triple-Analysis-Leukemia-Lymphoma-and-Pancreatic-Cancer.html This triple...

TOPICS:

S*BIO Restructures Agreement With Onyx for JAK2 Inhibitor Program

May 4, 2011 3:37 am | by Bio-Medicine.Org | Comments

SINGAPORE, May 4, 2011 /- S*BIO Pte Ltd today announced the restructuring of its collaboration and option agreement with Onyx Pharmaceuticals, which was entered into in January 2009. As a result, S*BIO has regained North American and European rights to its novel JAK2 inhibitors, SB1518...

TOPICS:

Onyx Pharmaceuticals Reports First Quarter 2011 Financial Results

May 4, 2011 3:37 am | by Bio-Medicine.Org | Comments

SOUTH SAN FRANCISCO, Calif., May 4, 2011 /- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX ) today reported its financial results for the first quarter 2011. Onyx reported a non-GAAP net loss of $14.2 million, or $0.23 per diluted share, for the first quarter 2011 compared to a non-GAAP net...

TOPICS:

Auxilium Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference

May 4, 2011 3:37 am | by Bio-Medicine.Org | Comments

MALVERN, Pa., May 4, 2011 /- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) today announced that executive management will participate in the Bank of America Merrill Lynch 2011 Health Care Conference during May 10-12, 2011 at the Encore at Wynn Las Vegas.  Mr. Armando Anido, Chief...

TOPICS:

Reportlinker Adds Latin American Markets for Dental Implants, Final Abutments and Computer Guided Surgery 2011 (Argentina, Brazil and Mexico)

May 4, 2011 3:34 am | by Bio-Medicine.Org | Comments

NEW YORK, May 4, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Latin American Markets for Dental Implants, Final Abutments and Computer Guided Surgery 2011 (Argentina, Brazil and Mexico)...

TOPICS:

Reportlinker Adds European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011

May 4, 2011 3:33 am | by Bio-Medicine.Org | Comments

NEW YORK, May 4, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011...

TOPICS:

MDCT arthrography accurately identifies

May 3, 2011 11:33 pm | by EurekAlert | Comments

(American Roentgen Ray Society) MDCT arthrography is better than MR arthrography for diagnosing glenoid rim osseous lesions, lesions that have been identified as potential causes of recurrence after shoulder surgery, according to a new study.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading